ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC
BackgroundACYP1 plays important physiological and metabolic roles in glycolysis and membrane ion pump activity by catalyzing acyl phosphate hydrolysis. ACYP1 is related to tumorigenesis and progression and poor prognosis in gastrointestinal cancer. However, its pancancer roles and mechanisms are unc...
Main Authors: | Lingyi Zhou, Zheng Fu, Shuai Wang, Jing Jia, Yumeng Cheng, Yunxiang Zheng, Ningning Zhang, Wei Lu, Zhi Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.875097/full |
Similar Items
-
CCNF is a potential pancancer biomarker and immunotherapy target
by: Lifang Wei, et al.
Published: (2023-04-01) -
Association between ACYP2 polymorphisms and the risk of renal cell cancer
by: Yuhe Wang, et al.
Published: (2019-11-01) -
The influence of ACYP2 polymorphisms on gastrointestinal cancer susceptibility in the Chinese Han population
by: Xianglong Duan, et al.
Published: (2019-07-01) -
The Prognostic and Therapeutic Role of Histone Acetylation Modification in LIHC Development and Progression
by: Ji Gao, et al.
Published: (2023-09-01) -
Integrative and Comprehensive Pancancer Analysis of Regulator of Chromatin Condensation 1 (RCC1)
by: Changwu Wu, et al.
Published: (2021-07-01)